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ABSTRACT
The global epidemic of metabolic syndrome (MS) correlates with changes in the environment, feeding, behav-
ior and lifestyle, leading to obesity, glucose intolerans, dyslipidemià ànd elevated cardiovascular risk. AIM:
The aim of our study was to develop an experimental model of the MS in rat that imitate the investigated met-
abolic disorders using high-fructose diet. METHODS: We used two groups: control group (C)- rats, main-
tained on plain water (n=6); fructose group (FRU)- rats received 12.5% high-fructose corn syrup in drinking
water for 12 weeks (n=6). The main markers of metabolic abnormalities (glucose, total cholesterol, triglycer-
ides, uric acid, body and organs weight), the markers of oxidative stress (malondialdehyde (MDA), total
thiols) and C-reactive protein (CRP) - inflammatory marker were measured. RESULTS: Our data showed
hypercholesterolemia, hyperglycemia, hyperuricemia and significant elevated levels of CRP, MDA, body and
organs weight, and inhibited antioxidant defense in fructose- drinking rats. CONCLUSION: The experimen-
tal model will support our studies associated with pathophysiology and pharmacology of MS.
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INTRODUCTION
The metabolic syndrome is defined as the presense of three
or more of the listed criteria - visceral adiposity,
dyslipidemia (combination of low levels of high-density li-
poprotein cholesterol and high levels of triglyceride), high
fasting glucose and hypertension (1). Development of these
metabolic abnormalities predispose to high risk of oxida-
tive stress, type-2-diabetes, cardiometabolic risk and
nonalcoholic fatty liver disease (NAFLD) (4-7). The global
epidemic of MS is related with changes in the environment,
feeding, behavior and lifestyle. An important explanation
for about is elevation the consumption of high- fructose
corn syrup (HFCS), widely used in food industry as a
sweetener in soft drinks and many other foods (2,3).
Fructose-fed rats also develop features of MS. Different ani-
mal modelsofMS, were created characterizing a particular as-
pects of MS. Major methodological differences in terms of:
1. Species of animals used: normal Wistar rats;
normotensive and nonglucose tolerant Sprague Dawley
rats (SDRs); spontaneously hypertensive rats (SHRs)
and other.
2. Type of carbohydrate intake: fructose or sucrose.
Mor Oron-Herman et al.(2008) compare two animal models
of MS: the high-sucrose diet given to spontaneously hyper-
tensive rats (SHRs) and high- fructose diet given to Sprague
Dawley rats (SDRs) and thus demonstrate specific genetic
factors. They found that feeding fructose affects more SDRs
in terms of hyperinsulinemia, hypertriglyceridemia, and hy-
percholesterolemia, while SHRs develop mainly hyperten-
sion (8). Other authors reported the central role of nutritional
factors in the development of MS. They applied in their re-
search a high carbohydrate diet of normal rats.The results of
Busserolles et al. (2002) indicate that consumption of a
high-sucrose diet causes mainly oxidative stress (11),
whereas Thirunavukkarasu et al. (2004) reported that high-
fructose feeding to normal rats causes equally oxidative tis-
sue damage and hyperglycemia, hyperinsulinemia,
dyslipidemià, obesity, deposition of lipids in liver, kidney
and skeletal muscle (9,10). We chose this model as appropri-
ate for our future research.
The aim of our study was to develop an experimental
chronic model of MS indused by high- fructose diet on male
Wistar rats. The model of MS plays an important role in our
investigation on relationships between liver metabolic disor-
ders, oxidative stress and inflammation.We are data in the lit-
erature that liver is the magor target in MS (12).
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Male albino Wistar rats were housed in a 20+2oC room
temperature and with a standard 12-h light/ dark cycle.
They all received a standard diet and water ad libitum. The
standard diet was composed of starch - 50%, protein - 20%,
fat - 4,5%, 5% cellulose, standard vitamins and mineral
mix. At the beginning of experiment the body weight of rat
was 140-180 g. After acclimatization (two weeks) the ani-
mals were divided randomly into two groups: control group
(C)- rats, maintained on plain water (n= 6); fructose group
(FRU)- rats received 12.5% high-fructose corn syrup in
drinking water for 12 weeks (n= 6). Food intake was re-
corded daily and their weight was monitored weekly. At
the end of the experiments, the rats were killing with lethal
dose of thiopental. All manipulations were performed at
4-8oC. Analysis was performed immediately after thawing
of the samples. The experimental procedures were approved
by the Home Office for Care and Use of Laboratory Animals
and performed with a strong consideration for ethics of ani-
mal experimentation according to the International Guiding
Principles for Animal Research approved in Bulgaria.
Blood and tissue collection
At the termination of the experiment blood was collected
from the tail vein of rats after pre-narcosis with Thiopental
at a dose of 15 mg / kg i.p. Serum obtained (subject to rules
of good practice Lab) used to determine some biochemical
indicators on the same day, and froze the rest. Under gen-
eral anesthesia with Thiopental 30mg/kg (rapid intrave-
nous) conducted a laparotomy. We took different organs
for research, preparation of homogenate, and then was
quickly dissected and frozen.The weight of heart, liver, kid-
ney, testis and retroperitoneal fat were measured. Tissue
extracts were prepared by homogenisation with buffer
PBS- 50 mM, pH = 7.4 (1 g tissue, 9 ml of buffer) in ice us-
ing a teflon glass homogenizer (2000 rpm / 3 min).
Homogenates centrifuged in refrigerated centrifuge (4000
rpm / 10 min). Supernatant was used for analysis after hav-
ing identified the concentration of protein.
Biochemical assays
The blood concentrations of glucose, total cholesterol and
triglycerides (TG) were determined by commercial kits
(F.Hoffmann-La Roche Inc.), CRP by ELISA kit (Helica
biosystems, INC.). Uric acid (Folin reagent), MDA(method
of Porter (1976) and total thiols groups (method of Ellman)
in serum and tissue by spectrophotometric assays was mea-
sured. Liver fat was extracted by method of Folch et al. and
hepatic triglycerides were measured as above.
Statistical analyses
All results were expressed as means ± SEM as indicated in
the figures and table. Statistical significance of the studied
parameters analyzed by Student's t test. P values of less than
0.05 were regarded as significant. The statistical procedure
was performed with GraphPad InStat software.
RESULTS AND DISCUSSION
The results indicate metabolic disorders of experimental
chronic model of MS indused by high- fructose diet and pres-
ent changes inexperimentalgroupcompared tocontrolgroup.
Of the metabolic parameters statistically significant differ-
ences were found for glucose, CRP, uric acid in serum , and
not significant increase of total cholesterol in fructose
drinking rats compared with the control group (Table 1).
FRU rats developed signs of MS, including significant ele-
vated hepatic fat deposition (Table 1). At 12 weeks fructose
drinking rats increased body weight, statistically significant
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239 ±7.8 a b
Glucose / serum (mmol/l) 6,08 ±0.88 8.14 ±0.5 b
Total cholesterol /serum
(mmol/l)
0,81 ±0,24 1,29 ±0,24
Triglyceride / serum
(mmol/l)
0,89 ±0.1 0,86 ±0.09
Triglyceride / liver (mg/g) 11.8 ±1.2 15.7 ±0.98 b
CRP /serum (ng/ml) 24.91 ±1.16 27.75 ±0.42 b
Uric acid / serum (mol/l) 111.48 ±6.02 145.16 ±14.49 b
Uric acid / liver (mol/l) 28.32 ±1.8 33.46 ±5.64
Table.1. Markers of metabolic abnormalities measured
in the control and experimental groups.
Mean levels SEM;n= 6;C-control group rats;FRU-fructose-drinking rats;
P
a
< 0.0001 - statistical significance between initial and final body weight;
P
b
< 0.05 - statistical significance between treated and control groups.
Fig. 1. Percentage of weight gain during the
development of experimental model of MS
both between the FRU and control groups and between ini-
tial and final weight in each group (Table 1). Figure 1 pres-
ents the steady weight gain in the experimental rats during
the development of nutritional model of MS.
Figure 2 shows the increase in weight of various organs,
particularly statistically significant for retroperitoneal fat.
Unexpected levels of uric acid in serum and liver was in-
creased, confirming the data of other authors that the uric
acid has a causal role in fructose-induced MS (Table 1) (13).
We found marked oxidative stress in the group of FRU,
considering the increased lipid peroxidation (MDA) and al-
tered activities of antioxidant enzymes (Total thiols groups)
(Table 2).
Likely overproduction of free radicals and decreased anti-
oxidant activity as a result of hyperglycaemia in FRU rats
may suppress the activation of insulin receptor (10).
In conclusion, the results of our studies show that high-
fructose diet causes metabolic disorders in rats associated
with MS. Experimental models will support our future re-
search on the pathophysiology and pharmacology of MS.
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Fig. 2. Change of organ weights in experimental group
versus the control group
Groups Control (C) Fructose (FRU)
MDA / serum (mmol/l) 2,18 ± 0,2 2,38 ± 0.5
MDA / liver (mol /g pr.) 0,11 ± 0,02 0,15 ± 0,02
Total thiol groups / serum
(mmol/l)
0,89 ± 0.1 0,86 ± 0.09
Total thiol groups / liver
(mol/l)
612,5 ± 28,1 566,6 ± 32,3
Table.2. Markers of oxidative stress and antioxidative
capacity measured in the control and experimental
groups.
Mean levels  SEM;n= 6;C-control group rats;FRU-fructose-drinking rats
